Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | FEM1B |
| Upstream (Parents) |
|---|
| (<<) HSPA13 → FEM1B |
| (<<) PPP2R2D → FEM1B |
| (<<) ZNF45 → FEM1B |
| (<<) SOCS6 → FEM1B |
| Downstream (Children) |
|---|
| FEM1B → SLC22A11 (>>) |
| FEM1B → CNKSR2 (>>) |
| FEM1B → PTPRJ (>>) |
| FEM1B → PCSK1N (>>) |
| FEM1B → DPYSL4 (>>) |
| FEM1B → SIK2 (>>) |
| FEM1B → KCNAB2 (>>) |
| FEM1B → DOPEY2 (>>) |
| FEM1B → CACNA1C (>>) |
| FEM1B → LYST (>>) |
| FEM1B → PPP2R2D (>>) |
| FEM1B → ABL2 (>>) |
| FEM1B → N6AMT1 (>>) |
| FEM1B → P2RY1 (>>) |
